What A Second Trump Term Could Mean For FDA And CPSC <https://www.law360.com/health/articles/2257714?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-11-07&read_main=1&nlsidx=0&nlaidx=0> By Emily Field The historic reelection of former President Donald Trump could lead to shake-ups at the U.S. Food and Drug Administration and the U.S. Consumer Product Safety Commission, while questions remain about what policies he will enact. Read full article » <https://www.law360.com/health/articles/2257714?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-11-07&read_more=1&nlsidx=0&nlaidx=0> | Save to favorites » <https://www.law360.com/health/articles/2257714?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-11-07&read_later=1&nlsidx=0&nlaidx=0>